Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis

被引:79
|
作者
Okamura, Daryl M. [1 ]
Pasichnyk, Katie
Lopez-Guisa, Jesus M.
Collins, Sarah
Hsu, Daniel K. [2 ]
Liu, Fu-Tong [2 ]
Eddy, Allison A.
机构
[1] Univ Washington, Seattle Childrens Res Inst, Div Nephrol, Dept Pediat, Seattle, WA 98105 USA
[2] Univ Calif Davis, Med Ctr, Div Res Dermatol, Sacramento, CA 95817 USA
基金
美国国家卫生研究院;
关键词
chronic kidney disease; nephron loss; matrix degradation; tubular apoptosis; defective tissue remodeling; GALECTIN-3/AGE-RECEPTOR-3 KNOCKOUT MICE; EXPERIMENTAL MURINE SCHISTOSOMIASIS; INTRACELLULAR COLLAGEN DEGRADATION; INTERSTITIAL FIBROSIS; PICROSIRIUS-POLARIZATION; OBSTRUCTIVE NEPHROPATHY; CELL-GROWTH; APOPTOSIS; RECEPTOR; INJURY;
D O I
10.1152/ajprenal.00326.2010
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Okamura DM, Pasichnyk K, Lopez-Guisa JM, Collins S, Hsu DK, Liu F, Eddy AA. Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis. Am J Physiol Renal Physiol 300: F245-F253, 2011. First published October 20, 2010; doi: 10.1152/ajprenal.00326.2010.-Renal tubular cell apoptosis is a critical detrimental event that leads to chronic kidney injury in association with renal fibrosis. The present study was designed to investigate the role of galectin-3 (Gal-3), an important regulator of multiple apoptotic pathways, in chronic kidney disease induced by unilateral ureteral obstruction (UUO). After UUO, Gal-3 expression significantly increased compared with basal levels reaching a peak increase of 95-fold by day 7. Upregulated Gal-3 is predominantly tubular at early time points after UUO but shifts to interstitial cells as the injury progresses. On day 14, there was a significant increase in TdT-mediated dUTP nick end labeling-positive cells (129%) and cytochrome c release (29%), and a decrease in BrdU-positive cells (62%) in Gal-3-deficient compared with wild-type mice. The degree of renal damage was more extensive in Gal-3-deficient mice at days 14 and 21, 35 and 21% increase in total collagen, respectively. Despite more severe fibrosis, myofibroblasts were significantly decreased by 58% on day 14 in the Gal-3-deficient compared with wild-type mice. There was also a corresponding 80% decrease in extracellular matrix synthesis in Gal-3-deficient compared with wild-type mice. Endo180 is a recently recognized receptor for intracellular collagen degradation that is expressed by interstitial cells during renal fibrogenesis. Endo180 expression was significantly decreased by greater than 50% in Gal-3-deficient compared with wild-type mice. Taken together, these results suggested that Gal-3 not only protects renal tubules from chronic injury by limiting apoptosis but that it may lead to enhanced matrix remodeling and fibrosis attenuation.
引用
收藏
页码:F245 / F253
页数:9
相关论文
共 50 条
  • [41] Reduction of Tendon Fibrosis Using Galectin-3 Inhibitors
    Spielman, Amanda F.
    Griffin, Michelle F.
    Titan, Ashley L.
    Guardino, Nicholas
    Cotterell, Asha C.
    Akras, Deena
    Wan, Derrick C.
    Longaker, Michael T.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 154 (01) : 113 - 121
  • [42] Prognostic value of galectin-3, a novel marker of fibrosis
    Lok, Dirk J.
    Bruggink, Pieta W.
    van der Meer, Peter
    CLINICAL RESEARCH IN CARDIOLOGY, 2010, 99 (08) : 529 - 529
  • [43] ROLE OF GALECTIN-3 IN THE DEVELOPMENT OF IDIOPATHIC PULMONARY FIBROSIS
    Parmar, N.
    Tatler, A.
    Ford, P.
    Jenkins, G.
    THORAX, 2017, 72 : A48 - A48
  • [44] Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades
    Wang, Xiaoyin
    Gaur, Meenakshi
    Mounzih, Khalid
    Rodriguez, Hilda J.
    Qiu, Huiliang
    Chen, Ming
    Yan, Liqiu
    Cooper, Brian A.
    Narayan, Shilpa
    Derakhshandeh, Ronak
    Rao, Poonam
    Han, Daniel D.
    Nabavizadeh, Pooneh
    Springer, Matthew L.
    John, Constance M.
    CARDIOVASCULAR RESEARCH, 2023, 119 (15) : 2536 - 2549
  • [45] Galectin-3 Expression, Deposition in the Extracellular Matrix and Posttranslational Modifications are Altered Under Hypoxic Conditions
    Zimmermann, Lara
    Cella, Nathalie
    Bernardes, Emerson Soares
    Teixeira, Veronica Rodrigues
    De Sousa Andrade, Luciana Nogueira
    Roque-Barreira, Maria Cristina
    Rosa, Jose Cesar
    Chammas, Roger
    GLYCOBIOLOGY, 2009, 19 (11) : 1332 - 1332
  • [46] Role of Galectin-3 in Idiopathic Pulmonary Fibrosis Development
    Parmar, N. R.
    Mackinnon, A. C.
    Zetterberg, F.
    Ford, P.
    Jenkins, R. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [47] Novel mechanism that Trypanosoma cruzi uses to adhere to the extracellular matrix mediated by human galectin-3
    Moody, TN
    Ochieng, J
    Villalta, F
    FEBS LETTERS, 2000, 470 (03) : 305 - 308
  • [48] Galectin-3 as a Predictor of Myocardial Fibrosis in Kawasaki Disease
    Numano, Fujito
    Shimizu, Chisato
    Fernandez, Susan J.
    Vejar, Matthew
    Salgado, Andrea
    Tremoulet, Adriana H.
    Gordon, John B.
    Burns, Jane C.
    Daniels, Lori B.
    CIRCULATION, 2014, 130
  • [49] Galectin-3 Inhibition Reduces Cardiac Fibrosis and Prevents Progressive Heart Failure Following Myocardial Infarction
    Wang, Xiaoyin
    Gaur, Meenakshi
    Rodriguez, Hilda J.
    Mounzih, Khalil
    Qiu, Huiliang
    Chen, Ming
    Yan, Liqiu
    Derakhshandeh, Ronak
    Narayan, Shilpa
    Cooper, Brian
    Rao, Poonam
    Nabavizadeh, Pooneh
    Springer, Matthew L.
    John, Constance M.
    CIRCULATION, 2019, 140
  • [50] Galectin-3 is a potential mediator of aldosterone effects in vascular remodeling
    Calvier, L.
    Reboul, P.
    Martin-Fernandez, B.
    Lahera, V.
    Zannad, F.
    Cachofeiro, V.
    Lacolley, P.
    Rossignol, P.
    Lopez-Andres, N.
    CARDIOVASCULAR RESEARCH, 2012, 93 : S31 - S31